Creative Biolabs helps microbiome teams generate decision-grade data for Ruminococcus bromii—quantifying resistant-starch degradation, SCFA outputs, and partner synergy under rigorously controlled anaerobic conditions. Turn exploratory concepts into reproducible metrics that guide selection, formulation, and scale-up.
Global microbiome innovators choose Creative Biolabs for rigorous anaerobe handling, mechanism-centric assays, and transparent data packages that streamline internal reviews and regulatory-ready documentation.
 
 
 
 
 
	A growing body of research recognizes R. bromii as a keystone degrader of resistant starch (RS), initiating carbohydrate access for the wider community and enabling downstream SCFA networks, including butyrate via cross-feeding partners. These functions make R. bromii central to diet–microbiome interactions and precision prebiotic programs.
Mechanistically, R. bromii employs a membrane-anchored amylosome with specialized starch-binding proteins to adhere to and hydrolyze granular RS, releasing sugars that support proximal taxa. These traits create measurable, formulation-relevant readouts in vitro and in co-culture systems.
 
		From fecal/anaerobic enrichment matrices, R. bromii is selectively recovered using RS-enriched media and colony phenotyping under strict anaerobiosis. We prioritize strains showing strong particle-RS adhesion and hydrolysis, reflecting amylosome-mediated activity and cross-feeding potential. All steps emphasize oxygen protection and traceability for high-value isolates.
Species-level resolution for R. bromii is achieved with 16S rRNA and whole-genome sequencing, complemented by ANI to discriminate near neighbors. Genomic annotation highlights starch-active loci and amylosome components to inform functional hypotheses, build a searchable strain dossier, and support long-term lineage tracking.
We build R. bromii species/strain-level qPCR assays—validated against reference panels—to quantify abundance in fermentations, bioprocess runs, or complex consortia. Probes are aligned to conserved starch-utilization signatures where appropriate, enabling sensitive monitoring of R. bromii kinetics during process optimization and stability programs.
Using resistant starches and select oligosaccharides as substrates, we map R. bromii fermentation fingerprints, tracking acetate yields, pH, and gas, while modeling cross-feeding to butyrate producers in co-culture. These datasets guide formula design, partner matching, and pH/lactate controls that shape SCFA outcomes.
We scale R. bromii from bench (100 mL) to multi-liter under validated anaerobic controls. Each batch includes KQAs: viable counts, purity, RS-degradation potency, and metabolic fingerprints. Results steer bioreactor parameters, media selection, and harvest strategies, informing feasibility for later scale-up and formulation.
Given oxygen sensitivity, R. bromii requires tailored protection. We screen cryo-/lyoprotectants, freeze-drying or spray-drying conditions, and packaging atmospheres to maximize shelf stability and rapid revival with preserved RS-degrading activity—validated by post-recovery functional assays.
We evaluate R. bromii in mucin/epithelial co-cultures, quantifying TEER, tight-junction markers, and SCFA-mediated effects. Pairing with commensal partners tests synergy driven by R. bromii RS hydrolysis and glucose halos, generating decision-grade MoA data for claim substantiation and partner selection.
Mechanism-first assays center on R. bromii amylosome function—binding to granular RS, hydrolysis rates, and cross-feeding efficacy to butyrate producers. Results are tied to genetics/omics where useful, producing quantitative readouts that de-risk portfolio down-selection.
Receive/process samples under oxygen-free conditions; initiate RS-enriched pre-cultures for R. bromii recovery.
Isolate, dereplicate, and confirm R. bromii via 16S/WGS and ANI; assemble annotated strain dossiers.
Run amylosome adhesion/hydrolysis tests and fermentation profiling; add co-culture cross-feeding as needed.
Test barrier endpoints and SCFA-linked effects in relevant epithelial/mucus systems.
Define growth, harvest, and stabilization parameters tailored to R. bromii oxygen sensitivity.
Deliver data packages with methods, QC, and interpretation; align on scale-up or product-adjacent studies.
Decades of experience in microbiome and anaerobic research ensure dependable handling of delicate species like R. bromii.
From strain isolation to data interpretation, every step is coordinated for consistency and transparency.
Services are tailored to meet unique project goals, experimental setups, and research timelines.
Standardized procedures and stringent controls guarantee data accuracy and repeatability.
Clients receive continuous updates, technical consultation, and responsive scientific support throughout the project.
Trusted by academic and industrial researchers worldwide for excellence in microbiome contract research services.
As the primary initiator of resistant-starch breakdown, R. bromii drives acetate/formate production, cross-feeds butyrate producers, nourishes colonocytes, and stabilizes community structure—foundational for microbiome-focused diets and consortia engineering.
Leveraging starch degradation, R. bromii restores SCFA balance and counters dysbiosis; fiber plans should be personalized because low baseline R. bromii constrains acetate/formate yields and downstream butyrate generation.
In liver-fluke–infected mice, oral R. bromii increased acetate, activated PI3K/AKT anti-fibrotic signaling, and reinforced intestinal barrier integrity—suggesting microbiome-driven avenues to limit fibrogenesis and support hepatic resilience via acetate.
Infant cohorts associate lower R. bromii with higher atopic dermatitis risk; sustaining early resistant-starch degradation and cross-feeding boosts butyrate, strengthens gut maturation, and may reduce allergy trajectories later.
Mouse studies link higher R. bromii abundance to improved running; future athlete interventions may tune resistant-starch intake and microbial consortia to enhance motivation, energy harvest, signaling, and performance adaptation capacity.
Surface multi-enzyme amylosomes of R. bromii model efficient granular-starch deconstruction, informing prebiotic design, food processing, consolidated bioprocessing, and synthetic consortia engineering for carbohydrate-active system innovation in industrial and academic research.
 
		A client engaged Creative Biolabs to generate lab-scale R. bromii lyophilized powder for preliminary evaluation in a mouse colitis model. Using strain CAT# LBSX-0522-GF79, cultures were grown anaerobically at 37 °C for 48 h in PYG broth. Pre-experiments optimized harvest conditions and lyophilization parameters, followed by activity checks to confirm functional recovery post-process.
Quality control included Gram staining and continuous microscopic examination to verify purity (Gram-positive, no contamination), plus viability and activity verification after drying. The final deliverable was a white to light-yellow lyophilized powder (1 g/bag; 5 bags total) in foil packaging, recommended for storage at ≤4 °C with a documented one-year shelf life—ready for downstream RUO studies.
Fig.1 Gram staining of R. bromii. (Microscopic examination)
		
 
			Get the case study brochure to explore detailed insights into R. bromii lab-scale production.
Creative Biolabs also provide R. bromii products for researchers:
| Product Name | Catalog No. | Target | Product Overview | Size | Price | 
|---|---|---|---|---|---|
| Ruminococcus bromii Moore et al. | LBSX-0522-GF79 | Ruminococcus | Ruminococcus bromii was isolated from human faeces. | - | 
R. bromii acts as a keystone degrader of resistant starch in the human gut, initiating carbohydrate breakdown and supporting butyrate-producing partners through efficient cross-feeding mechanisms and short-chain fatty acid generation.
We process fecal or anaerobic enrichment samples under oxygen-free conditions, using resistant-starch–based media to selectively recover and characterize R. bromii strains with high starch-degrading and community-supporting capacity.
Yes. We deploy tiered co-cultures where R. bromii is paired with typical butyrogens and controls, monitoring pH, lactate, and SCFA to prevent confounding bloom dynamics while preserving interpretability.
We quantify adhesion to granular RS, hydrolysis rates, and soluble sugar release, then link these to cross-feeding responses in partner organisms and SCFA trends, yielding mechanism-anchored decision metrics.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2025 Creative Biolabs. All Rights Reserved.